CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831971007
- Phone
- 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Hallal David Director | Grant or award | +35,000 | 2,143,662 | ||
| 2024-06-06 | Bornstein Jeffrey S Director | Grant or award | +35,000 | 110,197 | ||
| 2024-06-06 | Vera Juan Director | Grant or award | +35,000 | 2,409,928 | ||
| 2024-06-06 | Tomasello Shawn Director | Grant or award | +35,000 | 70,000 | ||
| 2024-06-06 | Brenner Malcolm Director | Grant or award | +35,000 | 100,197 | ||
| 2024-05-21 | Brainard Diana Chief Executive Officer | Sale | −5,149 | $0.79 | $4K | 784,471 |
| 2024-05-17 | Hagen Brett R Chief Accounting Officer | Sale | −541 | $0.75 | $405 | 75,481 |
| 2024-05-17 | Brainard Diana Chief Executive Officer | Sale | −3,075 | $0.75 | $2K | 789,620 |
| 2024-05-17 | Sinha Vikas See Remarks | Sale | −3,143 | $0.75 | $2K | 1,129,996 |
| 2024-05-17 | Miller Edward General Counsel | Sale | −420 | $0.75 | $315 | 220,496 |
| 2024-05-03 | Brainard Diana Chief Executive Officer | Sale | −10,240 | $0.80 | $8K | 792,695 |
| 2024-05-03 | Sinha Vikas See Remarks | Sale | −4,957 | $0.80 | $4K | 1,133,139 |
| 2024-05-03 | Hagen Brett R Chief Accounting Officer | Sale | −1,597 | $0.80 | $1K | 76,022 |
| 2024-05-03 | Miller Edward General Counsel | Sale | −2,311 | $0.80 | $2K | 220,916 |
| 2024-04-22 | Miller Edward General Counsel | Sale | −757 | $0.75 | $568 | 223,227 |
| 2024-04-22 | Hagen Brett R Chief Accounting Officer | Sale | −480 | $0.75 | $360 | 77,619 |
| 2024-04-22 | Sinha Vikas See Remarks | Sale | −1,857 | $0.75 | $1K | 1,138,096 |
| 2024-04-19 | Brainard Diana Chief Executive Officer | Sale | −9,601 | $0.75 | $7K | 802,935 |
| 2024-04-19 | Miller Edward General Counsel | Sale | −626 | $0.75 | $470 | 223,984 |
| 2024-04-19 | Hagen Brett R Chief Accounting Officer | Sale | −473 | $0.75 | $355 | 78,099 |
Page 6 of 7 · 122 trades